← Evidence map

ReviewTherapeutic advances in hematology2026

From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes.

Guluzar Gulnur Itez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes. | OpenQuestion